Diagnosis of human immunodeficiency virus type 1 infection in infants by immune complex dissociation p24 assay

被引:12
作者
Paul, MO
Toedter, G
Hofheinz, D
Tetali, S
Pelton, S
Marecki, M
Brena, A
Abrams, EJ
Landesman, S
Pahwa, S
机构
[1] N SHORE UNIV HOSP,CORNELL UNIV MED COLL,DEPT PEDIAT,MANHASSET,NY
[2] HARLEM HOSP MED CTR,DEPT PEDIAT,NEW YORK,NY
[3] SUNY DOWNSTATE HOSP,DEPT PEDIAT,BROOKLYN,NY
[4] COULTER IMMUNOL,HIALEAH,FL
[5] BOSTON CITY HOSP,DEPT PEDIAT,BOSTON,MA 02118
关键词
D O I
10.1128/CDLI.4.1.75-78.1997
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Using immune complex dissociation (ICD), we retrospectively examined serum and plasma of 206 infants aged 0 to 4 months who were perinatally exposed to human immunodeficiency virus (HIV). All samples were analyzed in a blinded manner. Infection status was determined based on the results of HIV culture and Centers for Disease Control and Prevention classification. The overall diagnostic sensitivity of the assay was 59% (93 samples, 73 infants), and specificity was 100% (160 samples, 133 infants). When the samples were analyzed according to age, sensitivity was highest at age 1 to 2 months (17 of 21 infants, 81%). Sensitivities at other ages were 53% at <1 month, 55% at 2 to 3 months, and 48% at 3 to 4 months (9 of 17, 11 of 20, and 12 of 25 cases, respectively). In 11 evaluable cases there was a possible correlation of p24 antigen quantitation (in picograms per milliliter) with disease progression. We conclude that, as determined in this study, the ICD p24 is a rapid diagnostic assay for HIV infection with a sensitivity of >80% at 1 to 2 months of age and 100% specificity, as evaluated, up to 4 months of age.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 31 条
[1]  
[Anonymous], 1994, MMWR
[2]   SHORTENED SURVIVAL IN INFANTS VERTICALLY INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS WITH ELEVATED P24 ANTIGENEMIA [J].
ARLIEVSKY, NZ ;
POLLACK, H ;
RIGAUD, M ;
KAUL, A ;
KRASINSKI, K ;
BORKOWSKY, W .
JOURNAL OF PEDIATRICS, 1995, 127 (04) :538-543
[3]   ACID DISSOCIATION INCREASES THE SENSITIVITY OF P24-ANTIGEN DETECTION FOR THE EVALUATION OF ANTIVIRAL THERAPY AND DISEASE PROGRESSION IN ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PERSONS [J].
BOLLINGER, RC ;
KLINE, RL ;
FRANCIS, HL ;
MOSS, MW ;
BARTLETT, JG ;
QUINN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) :913-916
[4]   EARLY DIAGNOSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CHILDREN LESS-THAN MONTHS OF AGE - COMPARISON OF POLYMERASE CHAIN-REACTION, CULTURE, AND PLASMA ANTIGEN CAPTURE TECHNIQUES [J].
BORKOWSKY, W ;
KRASINSKI, K ;
POLLACK, H ;
HOOVER, W ;
KAUL, A ;
ILMETMOORE, T .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (03) :616-619
[5]  
BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718
[6]   DIAGNOSTIC UTILITY OF IMMUNE-COMPLEX-DISSOCIATED P24 ANTIGEN-DETECTION IN PERINATALLY ACQUIRED HIV-1 INFECTION IN RWANDA [J].
BULTERYS, M ;
FARZADEGAN, H ;
CHAO, A ;
DUSHIMIMANA, A ;
VOLTZ, A ;
NAWROCKI, P ;
KURAWIGE, JB ;
SAAH, AJ .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02) :186-191
[7]   THE USE OF VIRAL CULTURE AND P24-ANTIGEN TESTING TO DIAGNOSE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN NEONATES [J].
BURGARD, M ;
MAYAUX, MJ ;
BLANCHE, S ;
FERRONI, A ;
GUIHARDMOSCATO, ML ;
ALLEMON, MC ;
CIRARUVIGNERON, N ;
FIRTION, G ;
FLOCH, C ;
GUILLOT, F ;
LACHASSINE, E ;
VIAL, M ;
GRISCELLI, C ;
ROUZIOUX, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1192-1197
[8]   OPTIMAL CONDITIONS FOR RECOVERY OF THE HUMAN IMMUNODEFICIENCY VIRUS FROM PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
CASTRO, BA ;
WEISS, CD ;
WIVIOTT, LD ;
LEVY, JA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (11) :2371-2376
[9]  
CATTANEO E, 1992, PEDIATR AIDS HIV INF, V3, P183
[10]  
CHADWANI S, 1993, PEDIATR INFECT DIS J, V12, P96